Versantvoort CH - Search Results

1

Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment.

Brandon EF, Oomen AG, Rompelberg CJ, Versantvoort CH, van Engelen JG, Sips AJ. Brandon EF, et al. Among authors: versantvoort ch. Regul Toxicol Pharmacol. 2006 Mar;44(2):161-71. doi: 10.1016/j.yrtph.2005.10.002. Epub 2005 Dec 6. Regul Toxicol Pharmacol. 2006. PMID: 16337324

2

Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food.

Versantvoort CH, Oomen AG, Van de Kamp E, Rompelberg CJ, Sips AJ. Versantvoort CH, et al. Food Chem Toxicol. 2005 Jan;43(1):31-40. doi: 10.1016/j.fct.2004.08.007. Food Chem Toxicol. 2005. PMID: 15582193

3

Role of biokinetics in risk assessment of drugs and chemicals in children.

de Zwart LL, Haenen HE, Versantvoort CH, Wolterink G, van Engelen JG, Sips AJ. de Zwart LL, et al. Among authors: versantvoort ch. Regul Toxicol Pharmacol. 2004 Jun;39(3):282-309. doi: 10.1016/j.yrtph.2004.02.006. Regul Toxicol Pharmacol. 2004. PMID: 15135209

4

Monolayers of IEC-18 cells as an in vitro model for screening the passive transcellular and paracellular transport across the intestinal barrier: comparison of active and passive transport with the human colon carcinoma Caco-2 cell line.

Versantvoort CH, Ondrewater RC, Duizer E, Van de Sandt JJ, Gilde AJ, Groten JP. Versantvoort CH, et al. Environ Toxicol Pharmacol. 2002 Jul;11(3-4):335-44. doi: 10.1016/s1382-6689(01)00122-3. Environ Toxicol Pharmacol. 2002. PMID: 21782616

5

Effects of cadmium chloride on the paracellular barrier function of intestinal epithelial cell lines.

Duizer E, Gilde AJ, Versantvoort CH, Groten JP. Duizer E, et al. Among authors: versantvoort ch. Toxicol Appl Pharmacol. 1999 Mar 1;155(2):117-26. doi: 10.1006/taap.1998.8589. Toxicol Appl Pharmacol. 1999. PMID: 10053166

6

Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells.

Duizer E, van der Wulp C, Versantvoort CH, Groten JP. Duizer E, et al. Among authors: versantvoort ch. J Pharmacol Exp Ther. 1998 Oct;287(1):395-402. J Pharmacol Exp Ther. 1998. PMID: 9765361

7

Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells.

Versantvoort CH, Broxterman HJ, Lankelma J, Feller N, Pinedo HM. Versantvoort CH, et al. Biochem Pharmacol. 1994 Sep 15;48(6):1129-36. doi: 10.1016/0006-2952(94)90149-x. Biochem Pharmacol. 1994. PMID: 7945406

8

Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.

Versantvoort CH, Broxterman HJ, Pinedo HM, de Vries EG, Feller N, Kuiper CM, Lankelma J. Versantvoort CH, et al. Cancer Res. 1992 Jan 1;52(1):17-23. Cancer Res. 1992. PMID: 1309222

9

Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.

Versantvoort CH, Broxterman HJ, Feller N, Dekker H, Kuiper CM, Lankelma J. Versantvoort CH, et al. Int J Cancer. 1992 Apr 1;50(6):906-11. doi: 10.1002/ijc.2910500615. Int J Cancer. 1992. PMID: 1348241

10

Multidrug resistance in lung cancer.

Broxterman HJ, Versantvoort CH, Linn SC. Broxterman HJ, et al. Among authors: versantvoort ch. Cancer Treat Res. 1995;72:193-222. doi: 10.1007/978-1-4615-2630-8_10. Cancer Treat Res. 1995. PMID: 7702987 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters